175 related articles for article (PubMed ID: 19681813)
1. Pharmacokinetics for once- versus twice-daily tacrolimus formulations in de novo kidney transplantation: a randomized, open-label trial.
Wlodarczyk Z; Squifflet JP; Ostrowski M; Rigotti P; Stefoni S; Citterio F; Vanrenterghem Y; Krämer BK; Abramowicz D; Oppenheimer F; Pietruck F; Russ G; Karpf C; Undre N
Am J Transplant; 2009 Nov; 9(11):2505-13. PubMed ID: 19681813
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics for once-daily versus twice-daily tacrolimus formulations in de novo liver transplantation: a randomized, open-label trial.
Fischer L; Trunečka P; Gridelli B; Roy A; Vitale A; Valdivieso A; Varo E; Seehofer D; Lynch S; Samuel D; Ericzon BG; Boudjema K; Karpf C; Undre N
Liver Transpl; 2011 Feb; 17(2):167-77. PubMed ID: 21280190
[TBL] [Abstract][Full Text] [Related]
3. Comparison of pharmacokinetics and pathology for low-dose tacrolimus once-daily and twice-daily in living kidney transplantation: prospective trial in once-daily versus twice-daily tacrolimus.
Tsuchiya T; Ishida H; Tanabe T; Shimizu T; Honda K; Omoto K; Tanabe K
Transplantation; 2013 Jul; 96(2):198-204. PubMed ID: 23792649
[TBL] [Abstract][Full Text] [Related]
4. Tacrolimus pharmacokinetics of once- versus twice-daily formulations in de novo kidney transplantation: a substudy of a randomized phase III trial.
Wlodarczyk Z; Ostrowski M; Mourad M; Krämer BK; Abramowicz D; Oppenheimer F; Miller D; Dickinson J; Undre N
Ther Drug Monit; 2012 Apr; 34(2):143-7. PubMed ID: 22406656
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics in stable kidney transplant recipients after conversion from twice-daily to once-daily tacrolimus formulations.
van Hooff J; Van der Walt I; Kallmeyer J; Miller D; Dawood S; Moosa MR; Christiaans M; Karpf C; Undre N
Ther Drug Monit; 2012 Feb; 34(1):46-52. PubMed ID: 22249344
[TBL] [Abstract][Full Text] [Related]
6. Once-daily prolonged release tacrolimus in liver transplantation: Experts' literature review and recommendations.
Coilly A; Calmus Y; Chermak F; Dumortier J; Duvoux C; Guillaud O; Houssel-Debry P; Neau-Cransac M; Stocco J
Liver Transpl; 2015 Oct; 21(10):1312-21. PubMed ID: 26264233
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of once- versus twice-daily tacrolimus formulations in kidney transplant patients receiving expanded criteria deceased donor organs: a single-center, randomized study.
Cabello M; García P; González-Molina M; Díez de los Rios MJ; García-Sáiz M; Gutiérrez C; López V; Sola E; Burgos D; Hernández D
Transplant Proc; 2010 Oct; 42(8):3038-40. PubMed ID: 20970603
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics in stable heart transplant recipients after conversion from twice-daily to once-daily tacrolimus formulations.
Alloway R; Vanhaecke J; Yonan N; White M; Haddad H; Rábago G; Tymchak W; Diaz Molina B; Grimm M; Eiskjaer H; Karpf C; Undre N
J Heart Lung Transplant; 2011 Sep; 30(9):1003-10. PubMed ID: 21493098
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic study of conversion from tacrolimus twice-daily to tacrolimus once-daily in stable lung transplantation.
Méndez A; Berastegui C; López-Meseguer M; Monforte V; Bravo C; Blanco A; Camós S; Pou L; Roman A
Transplantation; 2014 Feb; 97(3):358-62. PubMed ID: 24492423
[TBL] [Abstract][Full Text] [Related]
10. Once-daily, prolonged-release tacrolimus vs twice-daily, immediate-release tacrolimus in de novo living-donor liver transplantation: A Phase 4, randomized, open-label, comparative, single-center study.
Shin MH; Song GW; Lee SG; Hwang S; Kim KH; Ahn CS; Moon DB; Ha TY; Jung DH; Park GC; Yun YI; Kim WJ; Kang WH; Kim SH; Jiang H; Lee S; Tak EY
Clin Transplant; 2018 Sep; 32(9):e13376. PubMed ID: 30098071
[TBL] [Abstract][Full Text] [Related]
11. Comparison of pharmacokinetics and pharmacogenetics of once- and twice-daily tacrolimus in the early stage after renal transplantation.
Niioka T; Satoh S; Kagaya H; Numakura K; Inoue T; Saito M; Narita S; Tsuchiya N; Habuchi T; Miura M
Transplantation; 2012 Nov; 94(10):1013-9. PubMed ID: 23073468
[TBL] [Abstract][Full Text] [Related]
12. Advagraf(®) , a once-daily prolonged release tacrolimus formulation, in kidney transplantation: literature review and guidelines from a panel of experts.
Caillard S; Moulin B; Buron F; Mariat C; Audard V; Grimbert P; Marquet P
Transpl Int; 2016 Aug; 29(8):860-9. PubMed ID: 26373896
[TBL] [Abstract][Full Text] [Related]
13. One-year follow-up of treatment with once-daily tacrolimus in de novo renal transplant.
Kitada H; Okabe Y; Nishiki T; Miura Y; Kurihara K; Terasaka S; Kawanami S; Tuchimoto A; Masutani K; Tanaka M
Exp Clin Transplant; 2012 Dec; 10(6):561-7. PubMed ID: 23082898
[TBL] [Abstract][Full Text] [Related]
14. Tacrolimus once daily (ADVAGRAF) versus twice daily (PROGRAF) in de novo renal transplantation: a randomized phase III study.
Krämer BK; Charpentier B; Bäckman L; Silva HT; Mondragon-Ramirez G; Cassuto-Viguier E; Mourad G; Sola R; Rigotti P; Mirete JO;
Am J Transplant; 2010 Dec; 10(12):2632-43. PubMed ID: 20840480
[TBL] [Abstract][Full Text] [Related]
15. Clinical Pharmacokinetics of Once-Daily Tacrolimus in Solid-Organ Transplant Patients.
Staatz CE; Tett SE
Clin Pharmacokinet; 2015 Oct; 54(10):993-1025. PubMed ID: 26038096
[TBL] [Abstract][Full Text] [Related]
16. Once-daily vs twice-daily tacrolimus for de novo living kidney transplantation patients including ABO/HLA compatible and incompatible: A randomized trial.
Okumi M; Unagami K; Furusawa M; Kakuta Y; IIzuka J; Takagi T; Shirakawa H; Shimizu T; Omoto K; Inui M; Ishida H; Tanabe K
Clin Transplant; 2018 Dec; 32(12):e13423. PubMed ID: 30318624
[TBL] [Abstract][Full Text] [Related]
17. Conversion of stable kidney transplant recipients from a twice daily Prograf-based regimen to a once daily modified release tacrolimus-based regimen.
Alloway R; Steinberg S; Khalil K; Gourishankar S; Miller J; Norman D; Hariharan S; Pirsch J; Matas A; Zaltzman J; Wisemandle K; Fitzsimmons W; First MR
Transplant Proc; 2005 Mar; 37(2):867-70. PubMed ID: 15848559
[TBL] [Abstract][Full Text] [Related]
18. Renal function and safety in stable kidney transplant recipients converted from immediate-release to prolonged-release tacrolimus.
Lauzurica R; Morales JM; van Hooff J;
Transpl Int; 2012 Jan; 25(1):48-55. PubMed ID: 21992068
[TBL] [Abstract][Full Text] [Related]
19. Once- versus twice-daily tacrolimus: are the formulations truly equivalent?
Barraclough KA; Isbel NM; Johnson DW; Campbell SB; Staatz CE
Drugs; 2011 Aug; 71(12):1561-77. PubMed ID: 21861541
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of Once-Daily Extended-Release Tacrolimus Tablets Versus Twice-Daily Capsules in De Novo Liver Transplant.
DuBay DA; Teperman L; Ueda K; Silverman A; Chapman W; Alsina AE; Tyler C; Stevens DR
Clin Pharmacol Drug Dev; 2019 Nov; 8(8):995-1008. PubMed ID: 30667591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
